Medicine Related Problems (MRPs) in Adult Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Abstract
Abstract Views: 363
Asthma and Chronic Obstructive Pulmonary disease (COPD) have been classified as non-communicable diseases by the World Health Organization (WHO). These diseases contribute to the occurrence of around 4.2 million deaths globally. Medicine related problems (MRPs) refer to incidents associated with medicine therapy that interfere in the desired health outcomes. Patients with asthma and/or COPD are likely to encounter MRPs due to ineffective treatment, adverse drug reactions (ADRs), and/or medication errors (MEs). Therefore, the current study aimed to identify the prevalence, causes, and risk factors of MRPs among adult patients with asthma and/or COPD. A systematic literature review was conducted using 13 databases. These databases included PubMed, NELM, Embase, Scopus, ISI Web of Knowledge, ScienceDirect, PsycInfo, British Nursing Index, Global heath, International Pharmaceutical Abstracts, PsycExtra, and Cochrane Library. ‘Medicine related problems (MRPs)’ ‘adults’ ‘asthma’ ‘adverse drug reactions (ADRs)’ ‘drug related problems (DRPs)’ ‘adverse drug events (ADEs)’ ‘medication errors (MEs)’, and ‘Chronic Obstructive Pulmonary Disease’ ‘(COPD)’ were used as search items. Only quantitative studies, which investigated MRPs in adult patients with asthma and/or COPD, were included. The results of the review retrieved initially 1146338 titles that were considered. The analysis of the titles of these studies identified 55 relevant abstracts, of which, 15 were included in the review. The data extracted from these studies showed that the MRPs had a prevalence rate of 39.8%, ADRs 4.6%, while MEs had a prevalence rate of 66.9%. The comparison of these prevalence rates showed that MEs and MRPs had a higher prevalence than ADRs. Theophylline was reported to have the highest prevalence rate of MRPs which required special consideration to ensure its safe use by patients. The findings of the current study would potentially provide insights pertaining to the reduction of the high rate of MRPs.
Downloads
References
World Health Organisation. Chronic respiratory diseases: asthma. http://www.who.int/respiratory/asthma/en/. Updated May 3, 2021.
Department of Health. An outcomes strategy for chronic obstructive pulmonary disease (COPD) and asthma in England. https://assets.publishing.service.gov.uk/media/5a7cc010e5274a2f304efd6e/dh_128428.pdf. Updated July 2011.
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee Report. Allergy. 2004;59(5):469–478. https://doi.org/10.1111/j.1398-9995.2004.00526.x
Hon KLE, Leung TF, Leung AKC. Clinical effectiveness and safety of montelukast in asthma. what are the conclusions from clinical trials and meta-analyses? Drug Des Devel Ther. 2014;8(1):839–850. https://doi.org/10.2147/DDDT.S39100
World Health Organisation. Chronic obstructive pulmonary diseases (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Updated March 16, 2023.
May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 215;36(1):4–10. https://doi.org/10.2500/aap.2015.36.3812
Nacul L, Soljak M, Samarasundera E. COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J Pub Health. 2010;33(1):108–116. https://doi.org/10.1093/pubmed/fdq031
Slot AHM, ‘t Veen JCCM, Chavannes NH, et al. Effectiveness of the assessment of burden of chronic obstructive pulmonary disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulmon Med. 2014;37(1):5–14. https://doi.org/10.1186/1471-2466-14-131
Fernandez-Llimos F, Faus MJ, Gastelurrutia MA, Baena I, Martínez-Martínez F. Evolution of the concept of drug-related problems: outcomes as the focus of the new paradigm. Pharm Prac. 2005;3(4):167–188.
Souza TT, Saez-Benito L, Correr CJ, Fernandez-Llimos F. Critical assessment of the systematic review on hospitalization resulting from medicine related problems. Br J Clin Pharmacol. 2014;78(6):1465–1466. https://doi.org/10.1111%2Fbcp.12461
Pharmaceutical Care Network Europe. Classification for drug related problems. https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf. Updated May 2020.
World Health Organisation. International drug monitoring: the role of national centres Report of a WHO Meeting. https://who-umc.org/media/2680/who-technical-report-498.pdf. Updated 1972.
National Health Service England. Improving medication error incident reporting and learning. http://www.england.nhs.uk/wp-content/uploads/2014/03/psa-med-error.pdf. Accessed November 23, 2014.
van den Bemt PM, Egberts TC, de Jong-van den Berg LT, Brouwers JR. Drug-realted problems in hospitalised patients. Drug Safety. 2000;22(4):321–333. https://doi.org/10.2165/00002018-200022040-00005
World Health Organisation. Essential medicine and health products. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed April 22, 2015.
Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
Banerjee A, Mbamalu D, Ebrahimi S, Khan AA, Chan Foo T. The prevalence of polypharmacy in elderly attenders to an emergency department – a problem with a need for an effective solution. Int J Emer Med. 2011;4(1):e22. https://doi.org/10.1186/1865-1380-4-22
Mosby. Mosby's Dictionary of Medicine, Nursing, & Health Professions. Elsevier Health Sciences; 2012.
World Health Organisation. Definition of an elderly person http://www.who.int/respiratory/copd/burden/en/. Accessed November 20, 2014.
Pharmaceutical Care Network Europe. Classification for drug related problems (revised 14-01-2010vm) V6.2. https://www.pcne.org/upload/files/11_PCNE_classification_V6-2.pdf. Updated January 1, 2010.
Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG. Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf. 2010;19(2):141–149. https://doi.org/10.1002/pds.1861
Handler SM, Wright RM, Ruby CM, Hanlon JT. Epidemiology of medication-related adverse events in nursing homes. Am J Geriat Pharmacoth. 2006;4(3):264–272. https://doi.org/10.1016/j.amjopharm.2006.09.011
Desalu OO, Onyedum CC, Adeoti AO, et al. Unmet needs in asthma treatment in a resource-limited setting: Findings from the survey patients and their physicians in Nigeria. PanAfrican Med J. 2013;16(1):e20. https://doi.org/10.11604/pamj.2013.16.20.2798
Abramson MJ, Bailey MJ, Couper FJ, et al. Are asthma medications and management related to deaths from asthma? Am J Resp Critical Care Med. 2001;163(1):12–18. https://doi.org/10.1164/ajrccm.163.1.9910042
Stephenson A, Seitz DP, Fischer HD, et al. Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia. Drugs and aging. 2012;29(3):213–223. https://doi.org/10.2165/11599480-000000000-00000
Suissa S, Patenaude V, Lapi F, Emst F. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax. 2013;68(11):1029–1036. https://doi.org/10.1136/thoraxjnl-2012-202872
Youkou A, Hasegawa T, Suzuki K, et al. Influence of obesity on control in asthmatic Japanese patients defined by the Japanese definition of obesity. Int Med. 2011;50(1):1911–1916. https://doi.org/10.2169/internalmedicine.50.5474
Hasegawa T, Koya T, Sakagami T, Toyabe S, et al. Asthma control and management changes in Japan: Questionnaire Survey. Int Med. 2012;51(1):567–574. https://doi.org/10.2169/internalmedicine.51.6586
Baba K, Hattori T, Yagi T, et al. Adherence with long-term asthma management in patients who experienced hospitalized asthma exacerbation. Allergol Int. 2009;58(2):217–224. https://doi.org/10.2332/allergolint.08-OA-0012
Gallelli L, Ferreri G, Colosino M, et al. 2002. Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. Pharmacol Res. 2002;47(6):493–499. https://doi.org/10.1016/S1043-6618(03)00003-3
Al-Jahdali H, Ahmed A, Al-Harbi A, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clinic Immunol. 2013;9(1):e8. https://doi.org/10.1186/1710-1492-9-8
Press VG, Arrora VM, Shah LM, et al. Misuse of respiratory inhalers in hospitalised patients with asthma or COPD. J Gen Intern Med. 2011;26(6):635–642. https://doi.org/10.1007/s11606-010-1624-2
Spitz DJ. An unusual death in asthmatic patient. Am J Foren Med Pathol. 2003;24(3):271–272. https://doi.org/10.1097/01.paf.0000083522.05957.61
Axelsson M, Emilsson M, Brink E, Lundgren J, Torén K, Lötvall JJ. Personality, adherence, asthma control and health-related quality of life in young adult asthmatics. Respir Med. 2009;103(7):1033–1040. https://doi.org/10.1016/j.rmed.2009.01.013
Barrueco M, Otero MJ, Ferández DGM, et al. Theraputic non-compliance in patients with chronic airway obstruction. Rev Clín Esp. 1987;180(6):293–295.
Díaz AA, Celli B, Celedón JC. Chronic obstructive pulmonary disease in Hispanics. A 9-year update. Am J Respir Critical Care Med. 2018;197(1):15–21. https://doi.org/10.1164/rccm.201708-1615PP
Gilthorpe MS, Lay-Yee R, Wilson RC, Walters S, Griffiths RK, Bedi R. Variations in hospitalization rates for asthma among Black and minority ethnic communities. Respir Med. 1998;92(1):642–648. https://doi.org/10.1016/S0954-6111(98)90511-X
Shireman TI, Heaton PC, Gay WE, Cluxton RJ, Moomaw CJ. Relationship between asthma drug therapy patterns and healthcare utilization. Anal Pharmacoth. 2002;36(4):557–564. https://doi.org/10.1345/aph.1A067
Lal D, Manocha S, Ray A, Vijayan VK, Kumar R. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease. J Basic Clin Physiol Pharmacol. 2015;26(5):443–451. https://doi.org/10.1515/jbcpp-2015-0006
Lindsay JT, Heaney LG. Nonadherence in difficult asthma – facts, myths, and a time to act. Patient Pref Adher. 2013;7(1):329–336. https://doi.org/10.2147/PPA.S38208
Jadad AR, Moher M, Brownman GP, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. Brit Med J. 2000;320(1):537–540. https://doi.org/10.1136/bmj.320.7234.537
Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Anal Inter Med. 2007;147(9):639–653. https://doi.org/10.7326/0003-4819-147-9-200711060-00009
Copyright (c) 2023 Emma Packer, Sulaf Assi, Abdullah Al-Hamid
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal
